Using MGMT-siRNAs and a novel liposome, LipoTrustTM EX Oligo for delivery, MGMT was efficiently knocked down in glioma cells lines, GBM-stem like cells, and in vivo glioma tumors. This evidence concerns the gene MGMT and central nervous system cancer.